IBT specializes in delivering top-notch reagents tailored for research and development purposes.
An animal model is a non-human species used in biomedical research because it can mimic aspects of a biological process or disease found in humans.
Disease-to-target discovery is the process of identification and early validation of targets involved in a disease.
Plates were seeded with MDCK cells one day prior to the assay. Antibody 1, Antibody 2, and the Internal Control were serially diluted to Concentrations 1-8 and incubated with Influenza B/Brisbane/60/2008 at a predetermined MOI. The antibody/virus mixture was added to the cells and incubated at 35°C for several days until sufficient cytopathic effect (CPE) was observed in the Virus Only control wells. Cells were stained with crystal violet. Viable cells stain bright purple.
The Microneutralization Assay is based on the principle that neutralizing antibodies have the capacity to inhibit or block the ability of a virus to infect host cells. By measuring the reduction in viral infectivity in the presence of specific antibodies, researchers can determine the neutralizing capability of these antibodies.
These assays are invaluable tools for understanding the immune response to viral infections and the assessment of vaccines. They provide important information about the presence and potency of neutralizing antibodies, which are crucial for protection against many viral diseases.
Microneutralization Assays are used to study the immune response to viral infections, vaccine efficacy, and the development of immunity in individuals or populations.
These assays play a critical role in evaluating the effectiveness of vaccines by assessing their ability to induce neutralizing antibodies.
MN assays are employed in seroepidemiological studies to estimate the prevalence of specific antibodies within a population, providing insights into the history and prevalence of viral infections.
Some MN assays are used for diagnostic purposes, especially for confirming the presence of antibodies to specific viruses, such as in the case of diagnosing certain viral diseases like measles or mumps.
Our team of scientists and technicians are highly skilled and experienced in conducting HAI assays, ensuring accurate and reliable results.
We understand the unique needs of each research project and provide customized assay designs to meet your specific requirements.
We prioritize efficiency without compromising on quality. Our streamlined processes and advanced equipment allow for quick turnaround times, ensuring you receive results promptly.
We maintain rigorous quality control measures throughout our operations, ensuring the accuracy and reproducibility of our assay results.
Our dedicated customer support team is always available to address your queries and provide assistance at every step of the process.